Sponsor Pipeline

ProGen. Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
0
Recruiting
3
Disease Areas
Active Trials by Phase
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06712615 Phase II Study of PG-102(MG12) Compared With Placebo in Obesity and Type 2 Diabetes Type 2 Diabetes Mellitus (T2DM) Active, Not Recruiting
NCT07187856 Phase 2 Randomized Study of PG-102 vs Placebo and Semaglutide in Type 2 Diabetes Mellitus Type 2 Diabetes Mellitus (T2DM) Not Yet Recruiting
NCT07677891 Phase II Study of Switching From Dulaglutide to PG-102(MG12) in Type 2 Diabetes Mellitus Type 2 Diabetes Not Yet Recruiting
Disease Areas
Get alerts when ProGen. Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free